tiprankstipranks
Bright Minds Biosciences (TSE:DRUG)
:DRUG
Canadian Market

Bright Minds Biosciences (DRUG) Technical Analysis

72 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is 1.48, suggesting Bright Minds Biosciences is a Sell.
Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 105.84, while Bright Minds Biosciences’s (DRUG) share price is C$115.66, making it a Buy.
Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 106.27, while Bright Minds Biosciences’s (DRUG) share price is C$115.66, making it a Buy.

Bright Minds Biosciences (DRUG) Pivot Points

Apr 14, 2026, 12:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
108.51
110.58
114.74
116.81
120.97
123.04
127.20
Fibonacci
110.58
112.96
114.43
116.81
119.19
120.66
123.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bright Minds Biosciences (DRUG) Moving Averages

Apr 14, 2026, 12:12 PM
Period
Simple
Exponential
MA5
111.87Buy
112.23Buy
MA10
104.93Buy
108.12Buy
MA20
102.80Buy
105.84Buy
MA50
106.74Buy
106.27Buy
MA100
108.34Buy
102.09Buy
MA200
84.20Buy
82.94Buy
Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 108.12, while Bright Minds Biosciences’s (DRUG) share price is C$115.66, making it a Buy.
Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 102.09, while Bright Minds Biosciences’s (DRUG) share price is C$115.66, making it a Buy.
Bright Minds Biosciences’s (DRUG) stock price is C$115.66 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 106.74, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is C$115.66 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 108.34, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is C$115.66 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 84.20, creating a Buy signal.

Bright Minds Biosciences (DRUG) Technical Indicators

Apr 14, 2026, 12:12 PM
Name
Value
Implied Action
RSI (14)
60.72
Neutral
STOCH (9,6)
94.95
Sell
STOCHRSI (14)
94.95
Sell
MACD (12,26)
1.48
Sell
ADX (14)
14.45
Buy
Williams %R
-12.79
Sell
CCI (14)
203.61
Sell
ATR (14)
5.02
-
Ultimate Oscillator
66.18
Neutral
ROC
15.63
Buy
Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 60.72, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 14.45, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is 203.61, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is 15.63, creating a Buy signal.

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators, DRUG is a Buy.
    What is DRUG’s RSI (14)?
    DRUG’s RSI (14) is 60.72, which suggests DRUG is a Neutral.
      What is DRUG’s MACD?
      DRUG’s MACD is 1.48, which suggests DRUG is a Sell.
        What is DRUG’s 5-day moving average?
        DRUG’s 5-day moving average is 111.87, which suggests DRUG is a Buy.
          What is DRUG’s 20-day moving average?
          DRUG 20-day moving average is 102.80, which suggests DRUG is a Buy.
            What is DRUG’s 50-day moving average?
            DRUG’s 50-day moving average is 106.74, which suggests DRUG is a Buy.
              What is DRUG’s 200-day moving average?
              DRUG’s 200-day moving average is 84.20, which suggests DRUG is a Buy.
                What is DRUG’s Williams % R (14)?
                DRUG’s Williams % R (14) is -12.79, which suggests DRUG is a Sell.
                  What is DRUG’s CCI (14)?
                  DRUG’s CCI (14) is 203.61, which suggests DRUG is a Sell.